Scinopharm Taiwan (TPE:1789) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1789 Scinopharm Taiwan Ltd TPE:1789
74 GF Score
Price NT$19.75
GF Value NT$24.82
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Scinopharm Taiwan FFO per Share?

FFO per Share only applies to REITs.

TPE:1789
74GF Score
Scinopharm Taiwan Ltd TPE:1789
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Scinopharm Taiwan (TPE:1789) Overvalued in 2026?

Based on GuruFocus' analysis, Scinopharm Taiwan stock appears to be undervalued. The current stock price of NT$19.75 is trading 20.4% below its estimated GF Value™ of NT$24.82. GuruFocus considers Scinopharm Taiwan to be Modestly Undervalued.

Key valuation signals for TPE:1789:

  • FFO per Share:
  • GF Value™: NT$24.82 vs. price of NT$19.75 (20.4% below fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the TPE:1789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scinopharm Taiwan Business Description

Address Nan-Ke 8th Road, No. 1, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Scinopharm Taiwan Ltd is mainly engaged in the manufacture of western medicines and other chemical materials, biological technology services, intellectual property rights, international trade, and the research, development, production, manufacture, and sales of Active Pharmaceutical Ingredients (API), albumin medicines, oligonucleotide medicines, peptide medicines, injections, and new small molecule drugs. The Company also provides related consulting and technical services and international trade for the above products. In addition, the Company sells chemical material reprocessed from material recycled from the Company's manufacturing process.
74GF Score

Get the complete analysis for TPE:1789

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$19.75
Price
NT$24.82
GF Value